NeutriSci International Inc.
TSX VENTURE : NU

NeutriSci International Inc.

January 19, 2016 09:00 ET

NeutriSci Announces 1st Canadian Distribution Agremeent and Initial Order With 7-Eleven Canada

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 19, 2016) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE:NU) the innovator and pioneer behind NeuEnergy™, announces its first Canadian distribution agreement with 7-Eleven Canada.

7-Eleven is an international chain of convenience stores that operates, franchises and licenses some 56,400 stores in 18 countries including 503 corporately owned and operated stores in Canada. 7-Eleven Inc. is headquartered in Dallas, Texas, U.S.A.

Starting at the end of February 2016, NeutriSci will ship the first Canadian orders of NeuEnergy™ to all 7-Eleven national distribution centers (Vancouver, Calgary and Toronto). 7-Eleven has indicated that all stores in Canada will be receiving product from this initial order, with subsequent weekly orders to follow beginning in the second week of March 2016.

NeutriSci President Mr. Glen Rehman stated, "This new distribution agreement represents a major step forward for NeutriSci and NeuEnergy. This partnership provides consumers all across Canada with a trusted retailer from which they will be able to purchase NeuEnergy. We couldn't be more excited about the long term potential of this agreement for both the direct revenue and the further distribution agreements that will ultimately follow from other Canadian retailers. We see this partnership as a very solid base in our global retail distribution program; driving strong revenues and establishing international brand recognition."

NeuEnergy™ is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about NeuEnergy. Visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman, President

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men's prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Contact Information